4//SEC Filing
Anglin Robert M 4
Accession 0001209191-11-007978
CIK 0000868368other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 10:11 AM ET
Size
16.0 KB
Accession
0001209191-11-007978
Insider Transaction Report
Form 4
Anglin Robert M
VP Quality & Regulatory
Transactions
- Exercise/Conversion
Common Stock
2011-02-07$2.34/sh+2,000$4,688→ 2,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2011-02-07−2,000→ 0 totalExercise: $2.34Exp: 2011-04-06→ Common Stock (2,000 underlying)
Holdings
- 10,000
Stock Option (Right to Buy)
Exercise: $11.91From: 2007-11-29Exp: 2016-11-29→ Common Stock (10,000 underlying) - 5,000
Stock Option (Right to Buy)
Exercise: $10.89From: 2009-02-12Exp: 2018-02-12→ Common Stock (5,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $11.27From: 2010-02-03Exp: 2019-02-03→ Common Stock (20,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $12.27From: 2011-01-28Exp: 2020-01-28→ Common Stock (10,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $10.72From: 2012-01-27Exp: 2021-01-27→ Common Stock (10,000 underlying) - 8,000
Stock Option (Right to Buy)
Exercise: $2.17Exp: 2011-10-16→ Common Stock (8,000 underlying) - 4,000
Stock Option (Right to Buy)
Exercise: $4.63Exp: 2014-01-02→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]Currently 100% vested.
- [F2]Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.
Documents
Issuer
ROCHESTER MEDICAL CORPORATION
CIK 0000868368
Entity typeother
Related Parties
1- filerCIK 0001450690
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 10:11 AM ET
- Size
- 16.0 KB